-
Low-Fat Diet Could Be a Weapon Against Breast Cancer
drugs
May 16, 2019
Low-Fat Diet Could Be a Weapon Against Breast Cancer.
-
UNSW study predicts more than 50% rise in chemotherapy demand by 2040
biospectrumasia
May 15, 2019
The modelling study by a team of researchers – including UNSW Medicine academics – was published recently
-
California Couple Awarded $2 Billion in Roundup Lawsuit
drugs
May 15, 2019
An elderly California couple who said their cancer was caused by Monsanto's weed killer Roundup was awarded just over $2 billion by a jury in Oakland on Monday.
-
Bone cells suppress cancer metastases
worldpharmanews
May 15, 2019
Bone cells suppress cancer metastases.
-
Skin Cancer Awareness Month: overcoming drug resistance in skin cancer
pharmaceutical-technology
May 13, 2019
Skin Cancer Awareness Month aims to raise awareness about prevention measures against the most common form of cancer. The death rates from skin cancers, particularly melanoma, continue to rise, largely due to the resistance of tumours to existing drugs.
-
CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer
americanpharmaceuticalreview
May 10, 2019
CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer.
-
ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035
drugs
May 10, 2019
ACS Sets Goal to Cut Cancer Mortality 40 Percent by 2035.
-
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer
worldpharmanews
May 10, 2019
Trastuzumab deruxtecan demonstrated clinically-meaningful response in patients with refractory HER2-positive metastatic breast cancer.
-
Prostate cancer mutation found to triple risk of death
pharmatimes
May 09, 2019
Prostate cancer mutation found to triple risk of death.
-
Raman scattering for non-invasive prostate cancer screening
europeanpharmaceuticalreview
May 07, 2019
Raman scattering for non-invasive prostate cancer screening.